SARS-Cov-2 infection in cancer patients, susceptibility, outcome and careArticle Published on 2022-11-012022-11-15 Journal: The American journal of the medical sciences [Category] COVID19(2023년), SARS, 진단, [키워드] anti-cancer treatment antibody benefit Cancer Cancer patients cancers Care coronavirus COVID-19 COVID-19 pandemic doses Factor generate healthy hematologic impacted implication increased risk individuals Infection knowledge observation outcome Pandemics Patient patients Perception problem response to vaccination risk SARS-CoV-2 SARS-COV-2 infection shown susceptibility Vaccines virus [DOI] 10.1016/j.amjms.2022.05.017 PMC 바로가기
Patient perspectives on window of opportunity clinical trials in early-stage breast cancer초기 유방암에서 임상 시험 기회의 창에 대한 환자의 관점Article Published on 2022-07-012022-09-11 Journal: Breast cancer research and treatment [Category] 임상, [키워드] absence altruism Analysis anti-cancer treatment approach barrier benefit Breast Breast cancer Cancer clinic clinical clinical trial clinical trials contribute COVID-19 COVID-19 pandemic Decision-making desire diagnosed Diagnosis drug Enrollment Factor family fitness Hope hypothetical identify increasingly indicated offered oncology participant Participation Patient Patient perspectives performed Perspective positive attitude receive recruited Research Side effect Side effects standard treatment therapy Treatment Trial weighed window Window of opportunity. women [DOI] 10.1007/s10549-022-06611-6 PMC 바로가기 [Article Type] Article
COVID-19 associated coagulopathy and thrombosis in cancerResearch article Published on 2022-05-012022-10-05 Journal: Thrombosis research [Category] COVID19(2023년), SARS, 임상, [키워드] adverse outcome amplify anti-cancer treatment Antithrombotic Cancer cancer patient caused clinical study clinically Coagulation Coagulopathy Combination COVID-19 COVID-19 infection COVID-19 vaccination D-dimer disease Disseminated intravascular coagulation effective Efficacy and safety evaluated haematological malignancy hypercoagulable immune response Immune suppression IMPROVE incidence Infection intensity lung cancer management outcome Patient patients Prophylaxis Pulmonary embolism risk Safe SARS-CoV-2 selected seroconversion rate Severe COVID-19 Infection Specific thromboembolic complications thrombosis thrombotic microangiopathy vaccination venous thromboembolic [DOI] 10.1016/j.thromres.2021.12.006 [Article Type] Research article
Safety of COVID-19 Vaccine in Patients with Cancer in a High-Volume Comprehensive Cancer CenterBrief Communications Published on 2022-02-112022-10-28 Journal: The oncologist [Category] COVID-19, MERS, [키워드] 48 hours Administered ADR ADRS Adverse Adverse drug reaction adverse event anti-cancer treatment anti-SARS-CoV-2 BNT162b2 Cancer Cancer center cancer patient Cancer patients case sery center Chemotherapy Cohort Comprehensive COVID-19 COVID-19 vaccine Efficacy and safety event Italian malignancy mRNA National outcome Patient patients treated Patients with cancer Pfizer-BioNTech platform reported resolved Result retrieved Safety solid tumor Treatment Vaccine [DOI] 10.1093/oncolo/oyab037 PMC 바로가기 [Article Type] Brief Communications
An observational study of hospitalized COVID-19 patients with cancer in San Diego countyObservational Study Published on 2022-02-022022-10-04 Journal: Future Oncology [Category] COVID19(2023년), MERS, SARS, 임상, [키워드] accumulating Admission Analysis anti-cancer treatment association Cancer cancer patient Cancer patients Chemotherapy Clinical characteristics clinical feature conducted covariate covariates COVID-19 COVID-19 infection COVID-19 severity death determine diagnosis of cancer diagnosis of COVID-19 Diego disease Evidence greater hematologic Hematologic malignancy heterogenous hospital Hospitalized hospitalized COVID-19 patient hospitalized patient Immunotherapy incidence inclusion criteria increased mortality Laboratory lung lung cancer lung involvement lung metastasis malignancy metastatic tumor morbidity and mortality Mortality multivariate logistic regression Odds ratio outcome Patient patients positive presenting receiving retrospective SARS-CoV-2 severity significantly increased solid tumor statistically significant susceptibility systemic anti-cancer therapy targeted therapy therapy Treatment were used with COVID-19 [DOI] 10.2217/fon-2021-1116 PMC 바로가기 [Article Type] Observational Study
T-cell immune response after mRNA SARS-CoV-2 vaccines is frequently detected also in the absence of seroconversion in patients with lymphoid malignanciesmRNA SARS-CoV-2 백신 후 T 세포 면역 반응은 림프 악성 종양 환자에서 혈청 전환이 없는 경우에도 자주 감지됩니다Clinical Trial Published on 2022-02-012022-09-12 Journal: British Journal of Haematology [Category] COVID19(2023년), MERS, SARS, 임상, 진단, 치료기술, [키워드] absence affected age and sex Analysis anti-cancer treatment anti-CD20 Anti-CD20 antibodies Anti-CD20 antibody anti-CD20 treatment antibody B-cell lymphoma cellular Chemotherapy treatment Complete conducted COVID-19 Diagnosis evaluated healthy subject Humoral response immune immune response Immunoglobulin increased mortality independent predictor lowest lymphoid lymphoid malignancies. lymphoma maintain malignancies malignancy Measures mRNA mRNA vaccination Multiple myeloma Patient Prospective Study Protective raise receiving Result SARS-CoV-2 vaccine Seroconversion seroconversion rate serological serological response seronegative patient subgroup of patient T-cell T-cell immune response T-cell Response Treatment vaccination [DOI] 10.1111/bjh.17877 PMC 바로가기 [Article Type] Clinical Trial
COVID-19 outcomes of patients with gynecologic cancer in New York City: An updated analysis from the initial surge of the pandemicObservational Study Published on 2022-02-012022-10-05 Journal: Gynecologic oncology [Category] Coronavirus, 임상, [키워드] 95% confidence interval acute respiratory syndrome age Analysis anti-cancer treatment association Black race Cancer Chemotherapy Cohort Comorbidity coronavirus coronavirus disease Coronavirus disease 2019 Coronavirus disease 2019 (COVID-19) COVID-19 COVID-19 complications COVID-19 diagnosis COVID-19 hospitalization COVID-19 infection death Diagnosis Factor Fatality rate Gynecologic cancer hospital Hospitalization hospitalized patients ICU admission increased risk Infection initial interquartile range Invasive mechanical ventilation IQR Logistic regression malignancy mechanical ventilation Mortality multivariable analysis New York New York City Odds ratio oncology patient outcome outcomes pandemic Patient patients died performance status Predictive required SARS-CoV-2 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) significant increase smoking survived the median therapy with COVID-19 [DOI] 10.1016/j.ygyno.2021.12.004 PMC 바로가기 [Article Type] Observational Study
Patterns of neutralizing humoral response to SARS-CoV-2 infection among hematologic malignancy patients reveal a robust immune response in anti-cancer therapy-naive patients혈액 학적 악성 악성 환자들 사이에서 SARS-COV-2 감염에 대한 체액 반응을 중화시키는 패턴은 항암 치료-상대 환자에서 강력한 면역 반응을 나타낸다.Clinical Trial Published on 2022-01-182022-09-01 Journal: Blood Cancer Journal [Category] 임상, 진단, [키워드] analyzed anti-cancer treatment anti-SARS-CoV-2 humoral Chemotherapy COVID-19 cross-sectional cross-sectional study enhanced geometric geometric mean Haematological cancer Hematologic malignancy HM patient HM patients humoral IgG titers immune response Infection Infectious diseases lowest lymphoid malignancy Medical research natural infection neutralization titer Neutralizing Neutralizing activity Patient pattern PCR-confirmed Post-infection question raising receive receiving robust SARS-CoV-2 immunity SARS-COV-2 infection seroconversion rate seroconvert serum severe COVID-19 symptomatic symptomatic COVID-19 the patient therapy understanding Vaccination strategies Vaccination strategy Vaccine vulnerable population [DOI] 10.1038/s41408-022-00608-6 PMC 바로가기 [Article Type] Clinical Trial
The Impact of COVID-19 on the Delivery of Systemic Anti-Cancer Treatment at Guy’s Cancer CentreArticle Published on 2022-01-062022-10-31 Journal: Cancers [Category] COVID-19, [키워드] anti-cancer treatment can be used Cancer cancer patient cancer treatment Chemotherapy clinician Cohort collected comparable COVID-19 COVID-19 infection COVID-19 pandemic death rate decrease delivery demographics disease expected First wave help Immunotherapy Impact increase in increased risk infections Mortality oncology outcome pandemic Patient patients Prevalence real-world data receiving reduction in reflect SACT SARS-COV-2 infection SARS-CoV2 SARS-CoV2 infection Severe COVID-19 Infection significant effect significant increase significantly simple solid tumour subsequent Symptom systemic Systemic anti-cancer treatment Treatment vulnerable patients worsening [DOI] 10.3390/cancers14020266 PMC 바로가기 [Article Type] Article
Case Report: Clinical Management of a Patient With Metastatic Non-Small Cell Lung Cancer Newly Receiving Immune Checkpoint Inhibition During Symptomatic COVID-19증례 보고: 코로나19 증상이 있는 동안 면역 체크포인트 억제를 새로 받은 전이성 비소세포폐암 환자의 임상 관리Case Reports Published on 2021-12-202022-09-12 Journal: Frontiers in Immunology [Category] SARS, 진단, [키워드] activated ambulatory patient Analysis anti-cancer treatment anti-PD1 antiviral immunity blockade CD4 CD8 cellular change clinical Corticosteroid Course COVID-19 CT scan Effect feasible Follow-up healthy High-dose Hospitalized humoral immune response IgG immune checkpoint Immunotherapy inhibition initiated lesion lung cancer male malignancy management metastatic Neutralizing NSCLC Patient PD1 Pembrolizumab Pneumonia Pneumonitis presenting Radiographic SARS-CoV-2 SARS-CoV-2 clearance SARS-COV-2 infection serum sustained symptomatic T cell Tfh the patient treatment initiation worsened [DOI] 10.3389/fimmu.2021.798276 PMC 바로가기 [Article Type] Case Reports